
Delegates
Dr Stephanie Daly
General Practitioner
Dr Stephanie Daly is a GP based in Adelaide and the founder of Sensus Cognition, a primary care cognition clinic. She is the Lead GP Educator at Dementia Training Australia and also works as a GP contractor at Golden Grove Family Health. Dr Daly serves as a medical educator with the Royal Australian College of General Practice (RACGP), and sits on both the RACGP Training and Education Committee and the Women in General Practice Committee. She is an advisory board member for the Roche Educational Development Team for Alzheimer’s Disease and is an associate investigator on two National Health and Medical Research Council funded research grants. Her work is grounded in a commitment to improve dementia care within general practice, through both education and research.
Professor Christopher Rowe
Neurologist
Professor Christopher Rowe is a nuclear medicine physician and neurologist who serves as Director of the Australian Dementia Network, Director of Molecular Imaging Research at Austin Health and Professor at both The University of Melbourne and The Florey Institute. His research centres on molecular imaging and blood biomarkers of dementia, with the aim of improving understanding, enabling earlier and more accurate detection, and supporting the development of early therapeutic interventions. He is recognised as a Highly Cited Researcher, ranking in the top 1% globally in the field of neuroscience, and has received numerous national and international awards for his contributions.
Associate Professor Michael Woodward AM
Geriatrician
Associate Professor Michael Woodward AM is Director of Aged Care Research and lead clinician at the Memory Clinic at Austin Health in Melbourne, Victoria. He specialises in geriatric medicine, with a focus on Alzheimer’s disease and related dementias. He is the Principal Investigator for numerous clinical trials investigating new therapies for these conditions, and serves as a board member of the Dementia Australia Research Foundation, as well as one of four Honorary Medical Advisors to Dementia Australia.
He was awarded his MD for his research exploring the overlap between different dementia syndromes and the role of memory clinic data in deepening our understanding of these conditions. His more recent research has focused on characterising the frontal (dysexecutive) variant of Alzheimer’s disease.
He is Chair of the Accreditation Committee of the Royal Australasian College of Physicians (RACP) and has played an active role in the training programs of both the RACP and the Australia and New Zealand Society for Geriatric Medicine for over 30 years.
In recognition of his contributions to dementia and geriatric medicine, his involvement with numerous professional bodies, and his substantial body of academic publications and writings, he was appointed a Member of the Order of Australia on Australia Day in 2016.
Associate Professor Paul Yates
Geriatrician
Associate Professor Paul Yates is a Geriatrician and Early Career Clinician-Researcher with expertise in dementia and geriatric medicine across both hospital and community settings, including residential aged care. He is Deputy Director of Aged Care Research and Medical Lead for the Residential InReach Service at Austin Health, and also holds the position of Clinical Associate Professor in the Department of Medicine at Austin Health, The University of Melbourne.
Speakers
Professor Amy Brodtmann
Neurologist
Professor Amy Brodtmann leads the Cognitive Health Initiative within the Department of Neuroscience, School of Translational Medicine at Monash University. Prior to this, she held positions as Professor in The Florey Institute at The University of Melbourne and Honorary Adjunct Clinical Professor at Monash University.
She was also Professor and Co-Head of Behavioural Neuroscience at The Florey Institute for Neuroscience and Mental Health at the Melbourne Brain Centre, as well as a Consultant Neurologist at Austin Health.
Dr Pratishtha Chatterjee
Dementia Researcher
Dr Pratishtha Chatterjee is a leading dementia researcher and current Royce Simmons Foundation Mid-Career Research Fellow at The Florey Institute, The University of Melbourne. She was awarded her PhD by the University of Western Australia in 2015 for her work on blood-based biomarkers in Alzheimer’s disease. She later completed a postdoctoral fellowship at Macquarie University before joining The Florey. She also holds Honorary Research Fellow appointments at both Macquarie and Monash Universities.
Dr Stéphane Epelbaum
Neurologist
Dr Stéphane Epelbaum is a board-certified Neurologist with a PhD in neuroscience, who has helped redefine Alzheimer’s disease (AD) from an unspecific dementia to a distinct clinico-biological entity. For the past 15 years, he has been at the forefront of clinical AD research, participating in over 30 clinical trials. He was also a member of the AramisLab brain data science team, and contributed to the digital modelling of neurodegenerative diseases.
Dr Epelbaum has published more than 100 original articles in the field of AD and related disorders, with a focus on timely and accurate diagnosis and the development of new therapeutic options. He has contributed to guidelines as a member of the International Working Group, and to a consensus article on preclinical AD with the National Institute of Aging–Alzheimer Association. In recognition of his clinical research, he received the French Foundation Alzheimer Prize in 2018. Since 2021, he has led the medical affairs neurology team in the international business unit of Eli Lilly and Company, working to address clinical care gaps in neurological disorders.
Dr Andrew Gleason
Psychiatrist
Dr Andrew Gleason is a Senior Staff Specialist and Clinical Lead in the Department of Consultation-Liaison Psychiatry at Concord Hospital, Sydney, a role he has held since 2020. Since 2014, he has also worked as a Consultant in Old Age and Neuropsychiatry for the Huntington's Disease Service and Older Person's Mental Health Service in Launceston, Northern Tasmania, supported by the Rural Outreach Fund. In addition to this, he is an Honorary Principal Research Fellow at the Melbourne Dementia Research Centre, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne.
Professor Yun-Hee Jeon
Healthy Ageing Specialist
Professor Yun-Hee Jeon is Professor of Healthy Ageing at The University of Sydney. Trained as a registered nurse in both South Korea and Australia, she has dedicated the past 25 years to advancing the health and wellbeing of older adults in care through research and education. Her work spans evidence-building to knowledge translation, in person-centred dementia care, rehabilitation and workforce development in aged care. Professor Jeon has contributed to numerous national and international dementia-related initiatives, including the WHO’s Package of Interventions for Rehabilitation (Dementia) and their Mental Health Gap Action Programme update (Dementia module). She was also recognised as one of the UN’s Healthy Ageing 50.
Professor Ralph Martins AO
Neurobiologist
Professor Ralph Martins AO is the Convenor of the 2025 Australian Dementia Research Forum and Foundation Chair in Aging and Alzheimer’s Disease at Edith Cowan University, where he also serves as Director of the Centre of Excellence for Alzheimer’s Disease Research and Care. He completed his PhD at the University of Western Australia in 1986 before undertaking postdoctoral research at Heidelberg University under the mentorship of Professor Konrad Beyreuther. There, he played a pivotal role in isolating and characterising beta-amyloid and its precursor, the amyloid precursor protein, now recognised as central to the development of Alzheimer’s disease.
He was the first to propose and demonstrate the role of oxidative stress in Alzheimer’s pathology – a concept now widely accepted in the field. Over his distinguished career, he has held professorial and adjunct appointments at leading institutions, including the University of Western Australia, Curtin University and Thomas Jefferson University in the USA. He founded the Sir James McCusker Alzheimer’s Research Unit at Hollywood Hospital, whose research is focused on the diagnosis and treatment of Alzheimer’s disease.
A prolific researcher and editor, Professor Martins has served on editorial boards including the Journal of Alzheimer’s Disease and Current Drug Targets CNS & Neurological Disease. His work has received national and international recognition, including a prestigious Australian Broadcasting Corporation Media Fellowship, and continues to shape the landscape of dementia research and care in Australia and beyond.
Dr Elie Matar
Neurologist
Dr Elie Matar is a Consultant Neurologist and dual-trained Sleep Physician based at Royal Prince Alfred Hospital, as well as a Translational Clinician-Scientist supported by a National Health and Medical Research Council Emerging Leadership grant and Horizon Fellowship at The University of Sydney. He has developed subspecialty expertise in movement disorders and cognitive neurology through an Endeavour research fellowship at the University of Cambridge, UK, and dedicated clinical fellowships and visitorships at the National Hospital for Neurology and Neurosurgery in London, UK, and the Mayo Clinic Rochester, USA. Dr Matar currently leads a translational, multidisciplinary research program investigating the phenomenology, pathophysiology and progression of symptoms of synuclein-based diseases, including idiopathic REM sleep behaviour disorder, Parkinson’s disease and Lewy body dementia, on which he is considered a leading authority. His recent interests include the interplay between sleep and the manifestation and progression of disabling neurodegenerative symptoms. Despite being in the early stages of his career, Dr Matar has secured over A$5 million in grant funding supporting methods spanning neuroimaging, sleep neurophysiology, neuropathology, actigraphy, clinical phenotyping and clinical trials.
Professor Ben White
End-of-Life Law Specialist
Ben White is Professor of End-of-Life Law and Regulation and an Australian Research Council Future Fellow in the School of Law, Queensland University of Technology. He was a foundation Director of the Australian Centre for Health Law Research, and continues to co-lead its End-of-Life Research Program. With over 20 years of experience researching end-of-life law, policy, and practice, Professor White has contributed to interdisciplinary teams that have been awarded more than A$65 million in funding from sources including the Australian Research Council, the National Health and Medical Research Council, Commonwealth and State governments, and philanthropic organisations.
His current research focuses on voluntary assisted dying (VAD), including projects such as an Australian Research Council Future Fellowship on ‘Optimal Regulation of Voluntary Assisted Dying’, a national study of VAD in practice, and an exploratory study of dementia and VAD. Alongside colleagues, he played a key role in developing the mandatory training programs for clinicians providing VAD in Victoria, Western Australia and Queensland.
Professor Lily Xiao
Dementia Caregiving Specialist
Professor Lily Xiao is an internationally recognised Dementia Caregiver Researcher and one of four key contributors to the WHO iSupport for Dementia program, a skill training program for informal carers of people living with dementia. She has led research teams to adapt the WHO iSupport program in multiple languages tailored for the culturally and linguistically diverse (CALD) communities. Currently, she is leading a large National Health and Medical Research Council funded project evaluating the effectiveness and cost-effectiveness of a ‘Culturally tailored iSupport model of care’ for people with dementia and their carers from the CALD communities. Professor Xiao is a Fellow of Australian College of Nursing and serves on the Health Ageing Faculty. She is also a Foundation Member of the Australian Hartford Consortium for Gerontological Nursing Excellence. In recognition of her distinguished contributions to research and leadership, she has been awarded the prestigious title of ‘Matthew Flinders Professor’.
Associate Professor Mark Yates
Geriatrician
Associate Professor Mark Yates is a Consultant Geriatrician with the Grampians Region Cognitive, Dementia and Memory Service, and serves as a Clinical Associate Professor at Deakin University.
Alongside a team at Grampians Health Services, he developed the Dementia Care in Hospitals Program (DCHP), a comprehensive hospital-wide education initiative linked to the bedside Cognitive Impairment Identifier alert. From 2015 to 2017, with funding from an Australian Government grant, the DCHP was implemented and evaluated across four hospitals in four states and territories. It expanded to the Northern Territory in 2019, and was adopted by Redcliffe Hospital in 2020 for its Cognitive Impairment Support Program.
Dr Yates is a member of the Minister’s Dementia Reference Group, the National Aged Care Advisory Council and Safer Care Victoria’s Delirium Expert Working Group. He is a former member of the Pharmaceutical Benefits Advisory Committee and a past President of the Australian Medical Association Victoria.